Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspected Central Nervous System Tumors × Indocyanine Green × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 3 Suspected Central Nervous System Tumors 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms 1 Lymphoma 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1

Interventions

Indocyanine Green 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02710240 2021-10-27

Indocyanine Green for Central Nervous System Tumors

Abramson Cancer Center at Penn Medicine

Phase 1/2 Completed

336 enrolled 7 charts

Suspected Central Nervous System Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡